NL6804139A - - Google Patents

Info

Publication number
NL6804139A
NL6804139A NL6804139A NL6804139A NL6804139A NL 6804139 A NL6804139 A NL 6804139A NL 6804139 A NL6804139 A NL 6804139A NL 6804139 A NL6804139 A NL 6804139A NL 6804139 A NL6804139 A NL 6804139A
Authority
NL
Netherlands
Application number
NL6804139A
Other versions
NL156702B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6804139A publication Critical patent/NL6804139A/xx
Publication of NL156702B publication Critical patent/NL156702B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6804139A 1967-03-23 1968-03-22 Werkwijze voor de bereiding van een cefalosporinederivaat, alsmede gevormd preparaat met anti-bacteriele werking dat zo'n cefalosporinederivaat bevat. NL156702B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB03867/67A GB1208014A (en) 1967-03-23 1967-03-23 Cephalosporins

Publications (2)

Publication Number Publication Date
NL6804139A true NL6804139A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1968-09-24
NL156702B NL156702B (nl) 1978-05-16

Family

ID=10030837

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6804139A NL156702B (nl) 1967-03-23 1968-03-22 Werkwijze voor de bereiding van een cefalosporinederivaat, alsmede gevormd preparaat met anti-bacteriele werking dat zo'n cefalosporinederivaat bevat.

Country Status (7)

Country Link
CH (1) CH507984A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1770031A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK124265B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR7572M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1208014A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL156702B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE364284B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE36041B1 (en) * 1971-01-29 1976-08-04 Glaxo Lab Ltd Improvements in or relating to antibiotics
IL38657A (en) * 1971-01-29 1979-01-31 Glaxo Lab Ltd Hydroxyimino-and -acyloxyimino-acylamido cephalosporins
GB1389194A (en) * 1971-01-29 1975-04-03 Glaxo Lab Ltd Antibiotics
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
DE2710902A1 (de) 1977-03-12 1978-09-21 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
DE2818263A1 (de) * 1978-04-26 1979-11-08 Bayer Ag Beta-lactamantibiotika
IT1211080B (it) * 1981-07-21 1989-09-29 Craf Sud Idrazonocefem derivati biologicamente attivi.
GB8810393D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
WO2009130481A1 (en) 2008-04-24 2009-10-29 F2G Ltd Pyrrole antifungal agents
CN107207470B (zh) 2014-11-21 2019-12-03 F2G有限公司 抗真菌剂
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection

Also Published As

Publication number Publication date
GB1208014A (en) 1970-10-07
DK124265B (da) 1972-10-02
SE364284B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-02-18
CH507984A (de) 1971-05-31
NL156702B (nl) 1978-05-16
FR7572M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-01-05
DE1770031A1 (de) 1971-09-16
FR1556822A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1969-02-07

Similar Documents

Publication Publication Date Title
AU425114B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR7572M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU416737B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU342066A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU610966A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU3151267A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2256867A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1273466A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2116667A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2454867A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU3189468A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2528767A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2977667A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1763766A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE609869A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU25066A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1868267A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE483855A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU408412B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE477645A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1677166A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU459699A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1614766A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE692778A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU97666A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: GLAXO